Urine CMV PCR Positivity and Wheezing in Children under two Years Old: Implications for Management and Public Health

Objective: Wheezing in infants and toddlers poses a challenge to clinical management due to its multifaceted etiology, including viral infections. Cytomegalovirus (CMV) infection has been implicated in respiratory conditions, mostly in immunocompromised individuals, but its potential role in wheezing in young children remains understudied. Methods: A total of 82 children under two years of age with wheezing were enrolled in this study, including 61 infants (<12 >months) and 21 toddlers (12 to 24 months). Children were categorized into CMV-positive (n=49) and CMV-negative (n=33) groups based on urine PCR tests. Hematological profiles were examined on admission in all children. For CMV positive children, additional hematological evaluations were conducted at 2 weeks and 4 weeks following initiation of antiviral therapy. These children received a ganciclovir regimen (Induction: 5 mg/kg IV, q12h for 2 weeks; Maintenance: 5mg/kg IV q24h, 24 weeks). Results: On admission, CMV-positive children had significantly higher white blood cell (WBC) counts (12.16 vs. 8.39 ×109/L, P=0.004), leukocyte counts (6.92 vs. 4.49 ×109/L, P=0.010), and platelet counts (341.02 vs. 258.27 ×109/L, P=0.002) compared to CMV-negative children. During ganciclovir treatment, the elevated WBC, leukocyte, and platelet levels in CMV-positive children showed significant reductions by the second week, with further notable decreases by the fourth week (P<0.05). Notably, wheezing symptoms in CMV-positive children significantly improved after ganciclovir treatment, with subsequent negative CMV test results, indicating a favorable clinical response to antiviral therapy. Conclusion: Considering the multifaceted etiology of wheezing in children under two years of age, this study suggests that CMV infection may be one of the potential causes of wheezing symptoms. These findings highlight the importance of including CMV testing as part of the diagnostic evaluation for wheezing in this population to ensure more comprehensive management.

Authors

Publication Details

Journal
Journal of Pediatric Infectious Diseases
Published
2025-10-12
DOI
https://doi.org/10.53391/1305-7707.1043
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urine CMV PCR Positivity and Wheezing in Children under two Years Old: Implications for Management and Public Health

Dushuang Zuo, Zemin Su, Jing Wang, Zhaocheng Zeng et al.
Journal of Pediatric Infectious Diseases
Cytomegalovirus and herpesvirus research
article

Urine CMV PCR Positivity and Wheezing in Children under two Years Old: Implications for Management and Public Health

Dushuang Zuo, Zemin Su, Jing Wang, Zhaocheng Zeng, Xiaoyan Zhang
article en

Abstract

Objective: Wheezing in infants and toddlers poses a challenge to clinical management due to its multifaceted etiology, including viral infections. Cytomegalovirus (CMV) infection has been implicated in respiratory conditions, mostly in immunocompromised individuals, but its potential role in wheezing in young children remains understudied. Methods: A total of 82 children under two years of age with wheezing were enrolled in this study, including 61 infants (<12 >months) and 21 toddlers (12 to 24 months). Children were categorized into CMV-positive (n=49) and CMV-negative (n=33) groups based on urine PCR tests. Hematological profiles were examined on admission in all children. For CMV positive children, additional hematological evaluations were conducted at 2 weeks and 4 weeks following initiation of antiviral therapy. These children received a ganciclovir regimen (Induction: 5 mg/kg IV, q12h for 2 weeks; Maintenance: 5mg/kg IV q24h, 24 weeks). Results: On admission, CMV-positive children had significantly higher white blood cell (WBC) counts (12.16 vs. 8.39 ×109/L, P=0.004), leukocyte counts (6.92 vs. 4.49 ×109/L, P=0.010), and platelet counts (341.02 vs. 258.27 ×109/L, P=0.002) compared to CMV-negative children. During ganciclovir treatment, the elevated WBC, leukocyte, and platelet levels in CMV-positive children showed significant reductions by the second week, with further notable decreases by the fourth week (P<0.05). Notably, wheezing symptoms in CMV-positive children significantly improved after ganciclovir treatment, with subsequent negative CMV test results, indicating a favorable clinical response to antiviral therapy. Conclusion: Considering the multifaceted etiology of wheezing in children under two years of age, this study suggests that CMV infection may be one of the potential causes of wheezing symptoms. These findings highlight the importance of including CMV testing as part of the diagnostic evaluation for wheezing in this population to ensure more comprehensive management.

Journal of Pediatric Infectious DiseasesVol. 20(5)
Openalex Percentile: Top 61%
Cytomegalovirus and herpesvirus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.